Researcher
Leo Heyndrickx
- Disciplines:Virology
Projects
1 - 3 of 3
- To strengthen Institute of Tropical Medicine Pedro Kouri (IPK, Cuba) and National Institute of Hygiene, Epidemiology and Microbiology (INHEM, Cuba) towards accomplishment of their academic mission through capacity building and scientific co-operation.From1 Jan 2018 → 31 Dec 2018
- Strengthening the capacity for research, teaching, policy advice, advocacy and networking of the partners in the field of human and animal health (South-Africa).From1 Jan 2018 → 31 Dec 2018
- To strengthen the R&D capacities of the Institute of Tropical Medicine Alexander von Humboldt (Peru) to deliver strategies and/or tools for diagnosis, surveillance and control of infectious diseases.From1 Nov 2017 → 31 Dec 2021
Publications
1 - 10 of 133
- Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients(2024)
Authors: I Etienne, Delphine Kemlin, Nicolas Gemander, Véronique Olislagers, Alexandra Waegemans, Emilie Dhondt, L Heyndrickx, S Depickere, A Charles, M Goossens, et al.
Pages: 1857-1860 - Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination(2024)
Authors: C De Bouver, J Bouziotis, Veerle P W M Wijtvliet, Kevin Ariën, Joachim Mariën, L Heyndrickx, Marie-Madeleine Couttenye, HJW de Fijter, Fabienne Mestrez, S Treille, et al.
- Hybrid immunity overcomes defective immune response to COVID-19 vaccination in kidney transplant recipients(2024)
Authors: Nicolas Gemander, Delphine Kemlin, Stéphanie Depickère, NS Kelkar, P Pannus, Shilpee Sharma, Alexandra Waegemans, Véronique Olislagers, Daphnée Georges, Emilie Dhondt, et al.
Pages: 635-648 - Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients(2023)
Authors: Delphine Kemlin, Nicolas Gemander, Stéphanie Depickère, Véronique Olislagers, Daphnée Georges, Alexandra Waegemans, Pieter Pannus, Anne Lemy, Maria E. Goossens, Isabelle Desombere, et al.
Pages: 649-658 - Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults(2023)
Authors: Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Daphnée Georges, Sarah Houben, Véronique Olislagers, Alexandra Waegemans, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, et al.
Pages: 2829-2836 - Five accelerated schedules for the tick-borne encephalitis vaccine FSME-Immun® in last-minute travellers: an open-label, single-Centre, randomized controlled pilot trial(2023)
Authors: N Berens-Riha, Petra Andries, Annelies Aerssens, Quentin Ledure, Yolien Vanderbeken, L Heyndrickx, Els Genbrugge, Achilleas Tsoumanis, Yven Van Herrewege, Kevin Ariën, et al.
- SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations(2023)
Authors: Andrew P Hederman, Harini Natarajan, L Heyndrickx, Kevin Ariën, Joshua A Wiener, Peter F Wright, Evan M. Bloch, Aaron A. R. Tobian, Andrew D Redd, Joel N Blankson, et al.
- Validation of a reporter cell line for flavivirus inhibition assays(2023)
Authors: Tatiana M T Rezende, Gabriella Macera, L Heyndrickx, J Michiels, Sandra Coppens, Hendrik Jan Thibaut, Kai Dallmeier, Marjan Van Esbroeck, Johan Neyts, Kevin Ariën, et al.
- Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients(2022)
Authors: Lorenzo Canti, Kevin Ariën, Isabelle Desombere, Stephanie Humblet-Baron, Pieter Pannus, L Heyndrickx, Aurelie Henry, Sophie Servais, Evelyne Willems, Gregory Ehx, et al.
Pages: 335-337 - Chikungunya virus' high genomic plasticity enables rapid adaptation to restrictive A549 cells(2022)
Authors: Lien De Caluwé, L Heyndrickx, Sandra Coppens, K Vereecken, Miguel E Quiñones-Mateu, Andres Merits, Kevin Ariën, Koen Bartholomeeusen